| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 47 |
| 1 | IPILIMUMAB | 33 |
| 2 | PEMBROLIZUMAB | 30 |
| 3 | ATEZOLIZUMAB | 19 |
| 4 | CARBOPLATIN | 19 |
| 5 | DURVALUMAB | 12 |
| 6 | PACLITAXEL | 9 |
| 7 | PACLITAXEL (AIBUMIN-BOUND) | 9 |
| 8 | PEMETREXED | 9 |
| 9 | PEMETREXED DISODIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENPULIMAB | 1 | 0.0102 |
| 1 | AVELUMAB | 7 | 0.0017 |
| 2 | DOSTARLIMAB | 2 | 0.0008 |
| 3 | IPILIMUMAB | 33 | 0.0008 |
| 4 | TREMELIMUMAB | 3 | 0.0007 |
| 5 | DURVALUMAB | 12 | 0.0006 |
| 6 | ZOLMITRIPTAN | 4 | 0.0006 |
| 7 | NIVOLUMAB | 47 | 0.0005 |
| 8 | PEMBROLIZUMAB | 30 | 0.0003 |
| 9 | MEGESTROL ACETATE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 75 | 0.0008 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 35 | 0.0007 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 14 | 0.0006 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |
| 5 | Platinum-based Drug [EPC] | 20 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 | 0.0000 |